HomeCompareCZMWY vs NNN

CZMWY vs NNN: Dividend Comparison 2026

CZMWY yields 1.41% · NNN yields 5.66%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NNN wins by $3.8K in total portfolio value· pulled ahead in Year 5
10 years
CZMWY
CZMWY
● Live price
1.41%
Share price
$28.85
Annual div
$0.41
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.7K
Annual income
$155.02
Full CZMWY calculator →
NNN
NNN REIT Inc.
● Live price
5.66%
Share price
$42.03
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.5K
Annual income
$2,622.67
Full NNN calculator →

Portfolio growth — CZMWY vs NNN

📍 NNN pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCZMWYNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CZMWY + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CZMWY pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CZMWY
Annual income on $10K today (after 15% tax)
$120.23/yr
After 10yr DRIP, annual income (after tax)
$131.77/yr
NNN
Annual income on $10K today (after 15% tax)
$481.32/yr
After 10yr DRIP, annual income (after tax)
$2,229.27/yr
At 15% tax rate, NNN beats the other by $2,097.50/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CZMWY + NNN for your $10,000?

CZMWY: 50%NNN: 50%
100% NNN50/50100% CZMWY
Portfolio after 10yr
$23.6K
Annual income
$1,388.85/yr
Blended yield
5.88%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

CZMWY
Analyst Ratings
1
Buy
2
Hold
1
Sell
Consensus: Hold
Altman Z
2.5
Piotroski
7/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+6.9% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CZMWY buys
0
NNN buys
2
PoliticianChamberTickerTypeAmountDate
Lisa McClain🏢 House$NNN▼ Sell$1,001 - $15,0002025-08-13
Lisa McClain🏢 House$NNN▲ Buy$1,001 - $15,0002025-06-17
Zoe Lofgren🏢 House$NNN▼ Sell$1,001 - $15,0002023-05-25
Ro Khanna🏢 House$NNN▼ Sell$1,001 - $15,0002022-01-20
Zoe Lofgren🏢 House$NNN▲ Buy$1,001 - $15,0002021-09-30
Zoe Lofgren🏢 House$NNN▼ Sell$1,001 - $15,0002020-03-23
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCZMWYNNN
Forward yield1.41%5.66%
Annual dividend / share$0.41$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6%
Portfolio after 10y$21.7K$25.5K
Annual income after 10y$155.02$2,622.67
Total dividends collected$1.5K$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldHold

Year-by-year: CZMWY vs NNN ($10,000, DRIP)

YearCZMWY PortfolioCZMWY Income/yrNNN PortfolioNNN Income/yrGap
1$10,841$141.45$10,735$614.96+$106.00CZMWY
2$11,744$143.32$11,572$708.43+$172.00CZMWY
3$12,711$145.09$12,531$819.53+$180.00CZMWY
4$13,747$146.76$13,633$952.29+$114.00CZMWY
5← crossover$14,858$148.34$14,909$1,111.84$51.00NNN
6$16,048$149.84$16,392$1,304.77$344.00NNN
7$17,322$151.25$18,129$1,539.52$807.00NNN
8$18,688$152.59$20,173$1,827.08$1.5KNNN
9$20,150$153.84$22,597$2,181.81$2.4KNNN
10$21,715$155.02$25,491$2,622.67$3.8KNNN

CZMWY vs NNN: Complete Analysis 2026

CZMWYStock

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries. It serves practicing ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, dental and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

Full CZMWY Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this CZMWY vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CZMWY vs SCHDCZMWY vs JEPICZMWY vs OCZMWY vs KOCZMWY vs MAINCZMWY vs ADCCZMWY vs EPRTCZMWY vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.